| scholarly article | Q13442814 |
| P50 | author | Florian Caiment | Q55274597 |
| Theo M C M de Kok | Q55453416 | ||
| Mark Gosink | Q56946460 | ||
| Julian Krauskopf | Q88153803 | ||
| P2093 | author name string | Kent J Johnson | |
| Roscoe L Warner | |||
| Deborah A Burt | |||
| Jiri Aubrecht | |||
| Jos C Kleinjans | |||
| Shelli J Schomaker | |||
| Patricia Chandler | |||
| P2860 | cites work | Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases | Q36365092 |
| Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations | Q36693002 | ||
| Identification of cardiac-related circulating microRNA profile in human chronic heart failure | Q36729339 | ||
| Role of B cells in antigen presentation of the hepatitis B core | Q36829085 | ||
| Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity | Q37656707 | ||
| Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? | Q37981140 | ||
| Diversifying microRNA sequence and function | Q38117040 | ||
| Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity. | Q38223363 | ||
| Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome | Q38312576 | ||
| Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study. | Q39456074 | ||
| Elevated Hepatic miR-22-3p Expression Impairs Gluconeogenesis by Silencing the Wnt-Responsive Transcription Factor Tcf7. | Q40716224 | ||
| Circulating MicroRNAs in Plasma of Hepatitis B e Antigen Positive Children Reveal Liver-Specific Target Genes | Q41549935 | ||
| miR-125b inhibits hepatitis B virus expression in vitro through targeting of the SCNN1A gene | Q42195546 | ||
| Extracellular miRNAs: the mystery of their origin and function | Q44235487 | ||
| Circulating miRNAs as potential biomarkers in Alzheimer's disease | Q44261737 | ||
| Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. | Q51327695 | ||
| Circulating microRNAs as potential markers of human drug-induced liver injury | Q60609564 | ||
| Pulmonary recruitment, adherence, and chemotaxis of neutrophils in a rat model of cirrhosis and pneumococcal pneumonia | Q68064107 | ||
| Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease | Q86847853 | ||
| Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma | Q87980389 | ||
| Insulin signalling and the regulation of glucose and lipid metabolism | Q24292020 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| Circulating microRNAs, potential biomarkers for drug-induced liver injury | Q24656209 | ||
| Inhibition of Alpha Interferon Signaling by Hepatitis B Virus | Q27478029 | ||
| Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential | Q28077959 | ||
| A pancreatic islet-specific microRNA regulates insulin secretion | Q28292726 | ||
| Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 | Q29547403 | ||
| MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins | Q29615034 | ||
| Characterization of microRNA expression profiles in normal human tissues | Q29615492 | ||
| Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition | Q33563882 | ||
| Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis | Q34082773 | ||
| Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies | Q34291952 | ||
| Mono-uridylation of pre-microRNA as a key step in the biogenesis of group II let-7 microRNAs | Q34305941 | ||
| miRBase: the microRNA sequence database | Q34564134 | ||
| Selective stabilization of mammalian microRNAs by 3' adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. | Q34951363 | ||
| IsomiRage: From Functional Classification to Differential Expression of miRNA Isoforms | Q35343481 | ||
| Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury | Q35379600 | ||
| A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. | Q35609609 | ||
| GenSensor Suite: A Web-Based Tool for the Analysis of Gene and Protein Interactions, Pathways, and Regulation | Q35614928 | ||
| miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades | Q35633577 | ||
| What is normal? Next generation sequencing-driven analysis of the human circulating miRNAOme | Q35918523 | ||
| Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children | Q36022680 | ||
| MicroRNAs in body fluids--the mix of hormones and biomarkers | Q36176435 | ||
| Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury. | Q36187981 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | DESeq2 | Q113018293 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| pathogenesis | Q372016 | ||
| biopsy | Q179991 | ||
| hepatotoxicity | Q1349821 | ||
| P304 | page(s) | e0177928 | |
| P577 | publication date | 2017-05-17 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human | |
| P478 | volume | 12 |
| Q52390860 | Accessible miRNAs as Novel Toxicity Biomarkers. |
| Q91874527 | Acetaminophen Overdose as a Potential Risk Factor for Parkinson's Disease |
| Q98950791 | Amplification-free profiling of microRNA-122 biomarker in DILI patient serums, using the luminex MAGPIX system |
| Q92709740 | CC motif chemokine ligand 16 inhibits the progression of liver cirrhosis via inactivating hepatic stellate cells |
| Q91624658 | Circulating microRNA Profiles in Acetaminophen Toxicity |
| Q91839658 | Comparison of microRNA expressions for the identification of chemical hazards in in vivo and in vitro hepatic injury models |
| Q49651931 | Diagnostic value of circulating microRNAs for liver cirrhosis: a meta-analysis |
| Q64068390 | Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus |
| Q92651928 | Direct Detection of miR-122 in Hepatotoxicity Using Dynamic Chemical Labeling Overcomes Stability and isomiR Challenges |
| Q90610339 | Drug-induced liver injury: a safety review |
| Q92705067 | EASL Clinical Practice Guidelines: Drug-induced liver injury |
| Q100991757 | Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective Study |
| Q90963083 | Latest advances in diagnosing and predicting DILI: what was new in 2017? |
| Q49862111 | MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury |
| Q47947610 | MicroRNAs as biomarkers for clinical studies |
| Q91779620 | Old problem, new solutions: biomarker discovery for acetaminophen liver toxicity |
| Q40960255 | Polymerase-free measurement of microRNA-122 with single base specificity using single molecule arrays: Detection of drug-induced liver injury. |
| Q89838165 | The MicroRNA-based Liquid Biopsy Improves Early Assessment of Lethal Acetaminophen Poisoning: A Case Report |
| Q60961914 | The diagnostic role of miR-122 in drug-induced liver injury: A systematic review and meta-analysis |
| Q50053201 | The human circulating miRNome reflects multiple organ disease risks in association with short-term exposure to traffic-related air pollution |
Search more.